Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

A1C EZ Glycohemoglobin Analysis System

K-Number: K161533 · 2017-06-16

Decision Date2017-06-16
Product CodeLCP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

A1C EZ Glycohemoglobin Analysis System is the device name listed in this FDA 510(k) record. The listed applicant is Biohermes Co., Ltd.. It received FDA 510(k) clearance on 2017-06-16 under 510(k) number K161533. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the A1C EZ Glycohemoglobin Analysis System?

A1C EZ Glycohemoglobin Analysis System is a medical device that received FDA 510(k) clearance on 2017-06-16. The listed applicant is Biohermes Co., Ltd.. The 510(k) number is K161533.

When did A1C EZ Glycohemoglobin Analysis System receive FDA 510(k) clearance?

A1C EZ Glycohemoglobin Analysis System received FDA 510(k) clearance on 2017-06-16, under 510(k) number K161533.

Who is the listed applicant for A1C EZ Glycohemoglobin Analysis System?

The FDA 510(k) record lists Biohermes Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for A1C EZ Glycohemoglobin Analysis System?

The FDA product code for A1C EZ Glycohemoglobin Analysis System is LCP.

Related Devices (Code: LCP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.